Overexpression of RANKL by invariant NKT cells enriched in the bone marrow of patients with multiple myeloma

by Spanoudakis, E, Papoutselis, M, Terpos, E, Dimopoulos, M A, Tsatalas, C, Margaritis, D, Rahemtulla, A, Kotsianidis, I, Karadimitris, A
Published 2016

Osteoprotegerin is a significant prognostic factor for overall survival in patients with primary systemic amyloidosis independent of the Mayo staging

by Kastritis, E, Gavriatopoulou, M, Dimopoulos, M A, Eleutherakis-Papaiakovou, E, Kanellias, N, Roussou, M, Pamboucas, C, Toumanidis, S T, Terpos, E
Published 2015

Increased circulating VCAM-1 correlates with advanced disease and poor survival in patients with multiple myeloma: reduction by post-bortezomib and lenalidomide treatment

by Terpos, E, Migkou, M, Christoulas, D, Gavriatopoulou, M, Eleutherakis-Papaiakovou, E, Kanellias, N, Iakovaki, M, Panagiotidis, I, Ziogas, D C, Fotiou, D, Kastritis, E, Dimopoulos, M A
Published 2016

Evaluating results from the multiple myeloma patient subset treated with denosumab or zoledronic acid in a randomized phase 3 trial

by Raje, N, Vadhan-Raj, S, Willenbacher, W, Terpos, E, Hungria, V, Spencer, A, Alexeeva, Y, Facon, T, Stewart, A K, Feng, A, Braun, A, Balakumaran, A, Roodman, G D
Published 2016

VEGF directly suppresses activation of T cells from ascites secondary to ovarian cancer via VEGF receptor type 2

by Gavalas, N G, Tsiatas, M, Tsitsilonis, O, Politi, E, Ioannou, K, Ziogas, A C, Rodolakis, A, Vlahos, G, Thomakos, N, Haidopoulos, D, Terpos, E, Antsaklis, A, Dimopoulos, M A, Bamias, A
Published 2012

High levels of periostin correlate with increased fracture rate, diffuse MRI pattern, abnormal bone remodeling and advanced disease stage in patients with newly diagnosed symptomat...

by Terpos, E, Christoulas, D, Kastritis, E, Bagratuni, T, Gavriatopoulou, M, Roussou, M, Papatheodorou, A, Eleutherakis-Papaiakovou, E, Kanellias, N, Liakou, C, Panagiotidis, I, Migkou, M, Kokkoris, P, Moulopoulos, L A, Dimopoulos, M A
Published 2016